PTEN and non-small cell lung carcinoma: In 2016, a meta-analysis by Xiao et al. involving 23 studies (some of them were discussed in this review) with around 2.500 NSCLC patients concluded that decreased PTEN expression detected by IHC was associated with shorter overall survival (OS), DFS and PFS [86].